-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$72.5026.31% Upside
Recent Analyst Forecasts and Stock Ratings
Disc Medicine, Inc. Frequently Asked Questions
-
What analysts cover Disc Medicine, Inc.?
Disc Medicine, Inc. has been rated by research analysts at Scotiabank, BMO Capital, Jefferies, H.C. Wainwright, Wells Fargo, Raymond James in the past 90 days.